arrow
C

Carlo Vancheri

university hospital “policlinico g. rodolico-san marco”
H指数:63
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lipoid Pneumonia: HRCT and MRI Spectrum, Diagnostic Pitfalls, and Imaging-Based Diagnostic Workflow—A Systematic Review

脂质性肺炎:HRCT和MRI谱、诊断误区及基于影像的诊断流程——一项系统综述

2026-05-300
OA
“When Immunity Backfires: meta-analysis on Sarcoidosis Reactivation in Cancer Patients Treated with Immune Checkpoint Inhibitors”

“当免疫力适得其反:免疫检查点抑制剂治疗癌症患者中肉芽肿病复发的荟萃分析”

2026-03-200
PRE
Chronic rhinosinusitis with nasal polyposis and biological agents: the ARIA-ITALY survey

慢性鼻窦炎伴鼻息肉与生物制剂:ARIA-ITALY调查

2025-11-012
PRE
“Effectiveness of Mepolizumab on Mucus Plug Reduction and Clinical Outcomes in Severe Eosinophilic Asthma: A Prospective Observational Study”

“Mepolizumab对黏液栓减少及严重嗜酸性粒细胞哮喘临床结局的影响:一项前瞻性观察性研究”

2025-10-250
PRE
Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients

中间α-1抗胰蛋白酶缺乏症患者中呼吸疾病的表型表达与个体化治疗:来自对选定患者队列的回顾性分析的证据

2025-09-250
PRE
Effect of the Arg16Gly β2-Adrenergic Receptor Polymorphism on Long-Term Mepolizumab Response and Clinical Remission in Severe Eosinophilic Asthma: A Genotype-Stratified, Multicenter Study

Arg16Gly β2-肾上腺素能受体多态性对重度嗜酸性粒细胞哮喘患者长期美泊利单抗应答及临床缓解的影响:一项按基因型分层、多中心研究

2025-09-230
OAAI
Arg16Gly 132-Adrenoreceptor Polymorphism in Severe EosinophilicAsthma: Implications for Mepolizumab Long-Term Effectiveness and Clinical Remission
2024-10-300
PRE
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences

类风湿关节炎和原发性干燥综合征的肺进行性纤维化: 异同

2024-10-300
OAAI